Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,373 | -328,066 | -235,070 | -142,053 | -65,327 |
| Depreciation Amortization | 7,377 | 24,402 | 16,849 | 9,271 | 3,728 |
| Accounts receivable | -1,040 | N/A | -1,334 | -1,131 | -317 |
| Accounts payable and accrued liabilities | 1,168 | -987 | -670 | -2,856 | -339 |
| Other Working Capital | -36,451 | -50,257 | -38,987 | -34,525 | -24,404 |
| Other Operating Activity | 18,019 | 67,128 | 45,509 | 30,511 | 13,343 |
| Operating Cash Flow | $-102,300 | $-287,780 | $-213,703 | $-140,783 | $-73,316 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 480 | 480 | 0 | N/A |
| PPE Investments | -6,653 | -11,955 | -9,888 | -9,143 | -5,175 |
| Net Acquisitions | N/A | 1,844 | 1,915 | 1,915 | N/A |
| Purchase Sale Intangibles | 0 | -597 | -247 | -165 | -165 |
| Other Investing Activity | 0 | -597 | -247 | -165 | -165 |
| Investing Cash Flow | $-6,653 | $-10,228 | $-7,740 | $-7,393 | $-5,340 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | -766 | -72 | -48 | -24 |
| Common Stock Issued | 10,873 | 128,093 | 50,000 | N/A | 0 |
| Other Financing Activity | 3,050 | 12,806 | 9,546 | 5,757 | 1,946 |
| Financing Cash Flow | $13,897 | $140,133 | $59,474 | $5,709 | $1,922 |
| Exchange Rate Effect | -219 | 188 | 64 | 179 | -2 |
| Beginning Cash Position | 401,425 | 559,112 | 559,112 | 559,112 | 559,112 |
| End Cash Position | 306,150 | 401,425 | 397,207 | 416,824 | 482,378 |
| Net Cash Flow | $-95,275 | $-157,687 | $-161,905 | $-142,288 | $-76,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,300 | -287,780 | -213,703 | -140,783 | -73,316 |
| Capital Expenditure | -6,653 | -11,955 | -9,888 | -9,143 | -5,175 |
| Free Cash Flow | -108,953 | -299,735 | -223,591 | -149,926 | -78,491 |